MedTrace Logo

Observational Study of the Use of 8% Capsaicin Patch in Children 0 to 18 Years Old

NCT05299294 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2024-09-24

No results posted yet for this study

Summary

Patients aged less than 18-y with validated 8% capsaicin patch treatment in routine healthcare will be offered to participate the study. If they accept it as well as their parents, they will be included in the study .

Medical data will be recorded and at home, the child or his family will collect pain assessment data.

Tolerance will be monitored at home by phone call from investigational team every 24 hours until normalization. (Less than 24 hours for 75%, 100% to 72 hours on unpublished personal series.) Children will be assessed via scales at inclusion and 1-month, 3-month and 6-month.

Conditions

Interventions

OTHER

Data collection

Collecting data on children receiving capsaicine 8% patch for localized neuropathic pain

Sponsors & Collaborators

  • Fondation de France

    collaborator OTHER

  • Fondation Apicil

    collaborator OTHER

  • University Hospital, Brest

    lead OTHER

Principal Investigators

  • Philippe J Le Moine, MD · CHRU of Brest

Eligibility

Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-12
Primary Completion
2027-05-12
Completion
2027-09-12

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05299294 on ClinicalTrials.gov